Oncocyte Corp Stock Piotroski F Score

OCX Stock  USD 3.40  0.10  3.03%   
This module uses fundamental data of OncoCyte Corp to approximate its Piotroski F score. OncoCyte Corp F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of OncoCyte Corp. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about OncoCyte Corp financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out OncoCyte Corp Altman Z Score, OncoCyte Corp Correlation, OncoCyte Corp Valuation, as well as analyze OncoCyte Corp Alpha and Beta and OncoCyte Corp Hype Analysis.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.
  
At this time, OncoCyte Corp's Short and Long Term Debt Total is fairly stable compared to the past year. Debt To Equity is likely to rise to 0.11 in 2025, whereas Net Debt is likely to drop (6.2 M) in 2025. At this time, OncoCyte Corp's Days Sales Outstanding is fairly stable compared to the past year. Book Value Per Share is likely to rise to 5.55 in 2025, whereas Price To Sales Ratio is likely to drop 13.90 in 2025.
At this time, it appears that OncoCyte Corp's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
5.0
Piotroski F Score - Unavailable
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Increase

Focus
Current Ratio Change

Increase

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

Increase

Focus

OncoCyte Corp Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to OncoCyte Corp is to make sure OncoCyte is not a subject of accounting manipulations and runs a healthy internal audit department. So, if OncoCyte Corp's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if OncoCyte Corp's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.02750.0231
Fairly Up
Pretty Stable
Total Current Liabilities7.6 M8.3 M
Significantly Down
Slightly volatile
Non Current Liabilities Total26.9 M48.4 M
Way Down
Slightly volatile
Total Assets49.1 M86.1 M
Way Down
Slightly volatile
Total Current Assets15.7 M12.3 M
Significantly Up
Slightly volatile

OncoCyte Corp F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between OncoCyte Corp's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards OncoCyte Corp in a much-optimized way.

About OncoCyte Corp Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Common Stock Shares Outstanding

9.24 Million

At this time, OncoCyte Corp's Common Stock Shares Outstanding is fairly stable compared to the past year.

OncoCyte Corp ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, OncoCyte Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to OncoCyte Corp's managers, analysts, and investors.
Environmental
Governance
Social

About OncoCyte Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze OncoCyte Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoCyte Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoCyte Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OncoCyte Stock Analysis

When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.